Report Cover

Global 2019-nCoV Assay Kit Market Research Report 2021


The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
    Nucleic Acid Detection Kit
    Antibody Detection Kit

Segment by Application
    Designated Hospital
    Diagnostic Center
    Scientific Research
    Port of Entry
    Individual
    Others

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Roche
    Seegene
    PharmACT
    Everlywell
    Biopanda
    Mylab Discovery
    Integrated DNA Technologies
    Cosara Diagnostics
    Solgent
    Kogene Biotech
    SD Biosensor
    Biosewoom
    Shanghai ZJ Bio-Tech
    Shanghai Geneodx Biotech
    INNOVITA
    Genomics Biotech (Wuhan)
    Zhongshan Daan Gene
    Sanaure
    Shanghai Bio-Germ
    Guangzhou Wonfo Bio-Tech
    Chengdu Boaojing Bio-Tech
    Beijing XABT
    Bioscience(Chongqing) Bio-Tech
    Maccura Bio-Tech
    Xiamen InnoDx
    Guangdong Hecin-Scientific
    Wuhan Easydiagnosis Biomedicine
    Curative
    Biolidics
1 2019-nCoV Assay Kit Market Overview
    1.1 Product Overview and Scope of 2019-nCoV Assay Kit
    1.2 2019-nCoV Assay Kit Segment by Type
        1.2.1 Global 2019-nCoV Assay Kit Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 Nucleic Acid Detection Kit
        1.2.3 Antibody Detection Kit
    1.3 2019-nCoV Assay Kit Segment by Application
        1.3.1 2019-nCoV Assay Kit Sales Comparison by Application: (2021-2027)
        1.3.2 Designated Hospital
        1.3.3 Diagnostic Center
        1.3.4 Scientific Research
        1.3.5 Port of Entry
        1.3.6 Individual
        1.3.7 Others
    1.4 Global 2019-nCoV Assay Kit Market Size Estimates and Forecasts
        1.4.1 Global 2019-nCoV Assay Kit Revenue 2016-2027
        1.4.2 Global 2019-nCoV Assay Kit Sales 2016-2027
        1.4.3 2019-nCoV Assay Kit Market Size by Region: 2016 Versus 2021 Versus 2027

2 2019-nCoV Assay Kit Market Competition by Manufacturers
    2.1 Global 2019-nCoV Assay Kit Sales Market Share by Manufacturers (2016-2021)
    2.2 Global 2019-nCoV Assay Kit Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global 2019-nCoV Assay Kit Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers 2019-nCoV Assay Kit Manufacturing Sites, Area Served, Product Type
    2.5 2019-nCoV Assay Kit Market Competitive Situation and Trends
        2.5.1 2019-nCoV Assay Kit Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest 2019-nCoV Assay Kit Players Market Share by Revenue
        2.5.3 Global 2019-nCoV Assay Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 2019-nCoV Assay Kit Retrospective Market Scenario by Region
    3.1 Global 2019-nCoV Assay Kit Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.2 Global 2019-nCoV Assay Kit Retrospective Market Scenario in Sales by Region: 2016-2021
    3.3 North America 2019-nCoV Assay Kit Market Facts & Figures by Country
        3.3.1 North America 2019-nCoV Assay Kit Sales by Country
        3.3.2 North America 2019-nCoV Assay Kit Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe 2019-nCoV Assay Kit Market Facts & Figures by Country
        3.4.1 Europe 2019-nCoV Assay Kit Sales by Country
        3.4.2 Europe 2019-nCoV Assay Kit Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific 2019-nCoV Assay Kit Market Facts & Figures by Region
        3.5.1 Asia Pacific 2019-nCoV Assay Kit Sales by Region
        3.5.2 Asia Pacific 2019-nCoV Assay Kit Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America 2019-nCoV Assay Kit Market Facts & Figures by Country
        3.6.1 Latin America 2019-nCoV Assay Kit Sales by Country
        3.6.2 Latin America 2019-nCoV Assay Kit Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa 2019-nCoV Assay Kit Market Facts & Figures by Country
        3.7.1 Middle East and Africa 2019-nCoV Assay Kit Sales by Country
        3.7.2 Middle East and Africa 2019-nCoV Assay Kit Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global 2019-nCoV Assay Kit Historic Market Analysis by Type
    4.1 Global 2019-nCoV Assay Kit Sales Market Share by Type (2016-2021)
    4.2 Global 2019-nCoV Assay Kit Revenue Market Share by Type (2016-2021)
    4.3 Global 2019-nCoV Assay Kit Price by Type (2016-2021)

5 Global 2019-nCoV Assay Kit Historic Market Analysis by Application
    5.1 Global 2019-nCoV Assay Kit Sales Market Share by Application (2016-2021)
    5.2 Global 2019-nCoV Assay Kit Revenue Market Share by Application (2016-2021)
    5.3 Global 2019-nCoV Assay Kit Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 Roche
        6.1.1 Roche Corporation Information
        6.1.2 Roche Description and Business Overview
        6.1.3 Roche 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 Roche Product Portfolio
        6.1.5 Roche Recent Developments/Updates
    6.2 Seegene
        6.2.1 Seegene Corporation Information
        6.2.2 Seegene Description and Business Overview
        6.2.3 Seegene 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 Seegene Product Portfolio
        6.2.5 Seegene Recent Developments/Updates
    6.3 PharmACT
        6.3.1 PharmACT Corporation Information
        6.3.2 PharmACT Description and Business Overview
        6.3.3 PharmACT 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 PharmACT Product Portfolio
        6.3.5 PharmACT Recent Developments/Updates
    6.4 Everlywell
        6.4.1 Everlywell Corporation Information
        6.4.2 Everlywell Description and Business Overview
        6.4.3 Everlywell 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Everlywell Product Portfolio
        6.4.5 Everlywell Recent Developments/Updates
    6.5 Biopanda
        6.5.1 Biopanda Corporation Information
        6.5.2 Biopanda Description and Business Overview
        6.5.3 Biopanda 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 Biopanda Product Portfolio
        6.5.5 Biopanda Recent Developments/Updates
    6.6 Mylab Discovery
        6.6.1 Mylab Discovery Corporation Information
        6.6.2 Mylab Discovery Description and Business Overview
        6.6.3 Mylab Discovery 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 Mylab Discovery Product Portfolio
        6.6.5 Mylab Discovery Recent Developments/Updates
    6.7 Integrated DNA Technologies
        6.6.1 Integrated DNA Technologies Corporation Information
        6.6.2 Integrated DNA Technologies Description and Business Overview
        6.6.3 Integrated DNA Technologies 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Integrated DNA Technologies Product Portfolio
        6.7.5 Integrated DNA Technologies Recent Developments/Updates
    6.8 Cosara Diagnostics
        6.8.1 Cosara Diagnostics Corporation Information
        6.8.2 Cosara Diagnostics Description and Business Overview
        6.8.3 Cosara Diagnostics 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.8.4 Cosara Diagnostics Product Portfolio
        6.8.5 Cosara Diagnostics Recent Developments/Updates
    6.9 Solgent
        6.9.1 Solgent Corporation Information
        6.9.2 Solgent Description and Business Overview
        6.9.3 Solgent 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.9.4 Solgent Product Portfolio
        6.9.5 Solgent Recent Developments/Updates
    6.10 Kogene Biotech
        6.10.1 Kogene Biotech Corporation Information
        6.10.2 Kogene Biotech Description and Business Overview
        6.10.3 Kogene Biotech 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.10.4 Kogene Biotech Product Portfolio
        6.10.5 Kogene Biotech Recent Developments/Updates
    6.11 SD Biosensor
        6.11.1 SD Biosensor Corporation Information
        6.11.2 SD Biosensor 2019-nCoV Assay Kit Description and Business Overview
        6.11.3 SD Biosensor 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.11.4 SD Biosensor Product Portfolio
        6.11.5 SD Biosensor Recent Developments/Updates
    6.12 Biosewoom
        6.12.1 Biosewoom Corporation Information
        6.12.2 Biosewoom 2019-nCoV Assay Kit Description and Business Overview
        6.12.3 Biosewoom 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.12.4 Biosewoom Product Portfolio
        6.12.5 Biosewoom Recent Developments/Updates
    6.13 Shanghai ZJ Bio-Tech
        6.13.1 Shanghai ZJ Bio-Tech Corporation Information
        6.13.2 Shanghai ZJ Bio-Tech 2019-nCoV Assay Kit Description and Business Overview
        6.13.3 Shanghai ZJ Bio-Tech 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.13.4 Shanghai ZJ Bio-Tech Product Portfolio
        6.13.5 Shanghai ZJ Bio-Tech Recent Developments/Updates
    6.14 Shanghai Geneodx Biotech
        6.14.1 Shanghai Geneodx Biotech Corporation Information
        6.14.2 Shanghai Geneodx Biotech 2019-nCoV Assay Kit Description and Business Overview
        6.14.3 Shanghai Geneodx Biotech 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.14.4 Shanghai Geneodx Biotech Product Portfolio
        6.14.5 Shanghai Geneodx Biotech Recent Developments/Updates
    6.15 INNOVITA
        6.15.1 INNOVITA Corporation Information
        6.15.2 INNOVITA 2019-nCoV Assay Kit Description and Business Overview
        6.15.3 INNOVITA 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.15.4 INNOVITA Product Portfolio
        6.15.5 INNOVITA Recent Developments/Updates
    6.16 Genomics Biotech (Wuhan)
        6.16.1 Genomics Biotech (Wuhan) Corporation Information
        6.16.2 Genomics Biotech (Wuhan) 2019-nCoV Assay Kit Description and Business Overview
        6.16.3 Genomics Biotech (Wuhan) 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.16.4 Genomics Biotech (Wuhan) Product Portfolio
        6.16.5 Genomics Biotech (Wuhan) Recent Developments/Updates
    6.17 Zhongshan Daan Gene
        6.17.1 Zhongshan Daan Gene Corporation Information
        6.17.2 Zhongshan Daan Gene 2019-nCoV Assay Kit Description and Business Overview
        6.17.3 Zhongshan Daan Gene 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.17.4 Zhongshan Daan Gene Product Portfolio
        6.17.5 Zhongshan Daan Gene Recent Developments/Updates
    6.18 Sanaure
        6.18.1 Sanaure Corporation Information
        6.18.2 Sanaure 2019-nCoV Assay Kit Description and Business Overview
        6.18.3 Sanaure 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.18.4 Sanaure Product Portfolio
        6.18.5 Sanaure Recent Developments/Updates
    6.19 Shanghai Bio-Germ
        6.19.1 Shanghai Bio-Germ Corporation Information
        6.19.2 Shanghai Bio-Germ 2019-nCoV Assay Kit Description and Business Overview
        6.19.3 Shanghai Bio-Germ 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.19.4 Shanghai Bio-Germ Product Portfolio
        6.19.5 Shanghai Bio-Germ Recent Developments/Updates
    6.20 Guangzhou Wonfo Bio-Tech
        6.20.1 Guangzhou Wonfo Bio-Tech Corporation Information
        6.20.2 Guangzhou Wonfo Bio-Tech 2019-nCoV Assay Kit Description and Business Overview
        6.20.3 Guangzhou Wonfo Bio-Tech 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.20.4 Guangzhou Wonfo Bio-Tech Product Portfolio
        6.20.5 Guangzhou Wonfo Bio-Tech Recent Developments/Updates
    6.21 Chengdu Boaojing Bio-Tech
        6.21.1 Chengdu Boaojing Bio-Tech Corporation Information
        6.21.2 Chengdu Boaojing Bio-Tech 2019-nCoV Assay Kit Description and Business Overview
        6.21.3 Chengdu Boaojing Bio-Tech 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.21.4 Chengdu Boaojing Bio-Tech Product Portfolio
        6.21.5 Chengdu Boaojing Bio-Tech Recent Developments/Updates
    6.22 Beijing XABT
        6.22.1 Beijing XABT Corporation Information
        6.22.2 Beijing XABT 2019-nCoV Assay Kit Description and Business Overview
        6.22.3 Beijing XABT 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.22.4 Beijing XABT Product Portfolio
        6.22.5 Beijing XABT Recent Developments/Updates
    6.23 Bioscience(Chongqing) Bio-Tech
        6.23.1 Bioscience(Chongqing) Bio-Tech Corporation Information
        6.23.2 Bioscience(Chongqing) Bio-Tech 2019-nCoV Assay Kit Description and Business Overview
        6.23.3 Bioscience(Chongqing) Bio-Tech 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.23.4 Bioscience(Chongqing) Bio-Tech Product Portfolio
        6.23.5 Bioscience(Chongqing) Bio-Tech Recent Developments/Updates
    6.24 Maccura Bio-Tech
        6.24.1 Maccura Bio-Tech Corporation Information
        6.24.2 Maccura Bio-Tech 2019-nCoV Assay Kit Description and Business Overview
        6.24.3 Maccura Bio-Tech 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.24.4 Maccura Bio-Tech Product Portfolio
        6.24.5 Maccura Bio-Tech Recent Developments/Updates
    6.25 Xiamen InnoDx
        6.25.1 Xiamen InnoDx Corporation Information
        6.25.2 Xiamen InnoDx 2019-nCoV Assay Kit Description and Business Overview
        6.25.3 Xiamen InnoDx 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.25.4 Xiamen InnoDx Product Portfolio
        6.25.5 Xiamen InnoDx Recent Developments/Updates
    6.26 Guangdong Hecin-Scientific
        6.26.1 Guangdong Hecin-Scientific Corporation Information
        6.26.2 Guangdong Hecin-Scientific 2019-nCoV Assay Kit Description and Business Overview
        6.26.3 Guangdong Hecin-Scientific 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.26.4 Guangdong Hecin-Scientific Product Portfolio
        6.26.5 Guangdong Hecin-Scientific Recent Developments/Updates
    6.27 Wuhan Easydiagnosis Biomedicine
        6.27.1 Wuhan Easydiagnosis Biomedicine Corporation Information
        6.27.2 Wuhan Easydiagnosis Biomedicine 2019-nCoV Assay Kit Description and Business Overview
        6.27.3 Wuhan Easydiagnosis Biomedicine 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.27.4 Wuhan Easydiagnosis Biomedicine Product Portfolio
        6.27.5 Wuhan Easydiagnosis Biomedicine Recent Developments/Updates
    6.28 Curative
        6.28.1 Curative Corporation Information
        6.28.2 Curative 2019-nCoV Assay Kit Description and Business Overview
        6.28.3 Curative 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.28.4 Curative Product Portfolio
        6.28.5 Curative Recent Developments/Updates
    6.29 Biolidics
        6.29.1 Biolidics Corporation Information
        6.29.2 Biolidics 2019-nCoV Assay Kit Description and Business Overview
        6.29.3 Biolidics 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
        6.29.4 Biolidics Product Portfolio
        6.29.5 Biolidics Recent Developments/Updates

7 2019-nCoV Assay Kit Manufacturing Cost Analysis
    7.1 2019-nCoV Assay Kit Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of 2019-nCoV Assay Kit
    7.4 2019-nCoV Assay Kit Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 2019-nCoV Assay Kit Distributors List
    8.3 2019-nCoV Assay Kit Customers

9 2019-nCoV Assay Kit Market Dynamics
    9.1 2019-nCoV Assay Kit Industry Trends
    9.2 2019-nCoV Assay Kit Growth Drivers
    9.3 2019-nCoV Assay Kit Market Challenges
    9.4 2019-nCoV Assay Kit Market Restraints

10 Global Market Forecast
    10.1 2019-nCoV Assay Kit Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of 2019-nCoV Assay Kit by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of 2019-nCoV Assay Kit by Type (2022-2027)
    10.2 2019-nCoV Assay Kit Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of 2019-nCoV Assay Kit by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of 2019-nCoV Assay Kit by Application (2022-2027)
    10.3 2019-nCoV Assay Kit Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of 2019-nCoV Assay Kit by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of 2019-nCoV Assay Kit by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global 2019-nCoV Assay Kit Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global 2019-nCoV Assay Kit Sales (K Units) Comparison by Application (2021-2027) Table 3. Global 2019-nCoV Assay Kit Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers 2019-nCoV Assay Kit Covered in This Study Table 5. Global 2019-nCoV Assay Kit Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global 2019-nCoV Assay Kit Sales Share by Manufacturers (2016-2021) Table 7. Global 2019-nCoV Assay Kit Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global 2019-nCoV Assay Kit Revenue Share by Manufacturers (2016-2021) Table 9. Global Market 2019-nCoV Assay Kit Average Price (US$/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers 2019-nCoV Assay Kit Manufacturing Sites and Area Served Table 11. Manufacturers 2019-nCoV Assay Kit Product Type Table 12. Global 2019-nCoV Assay Kit Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global 2019-nCoV Assay Kit by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in 2019-nCoV Assay Kit as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global 2019-nCoV Assay Kit Sales by Region (2016-2021) & (K Units) Table 16. Global 2019-nCoV Assay Kit Sales Market Share by Region (2016-2021) Table 17. Global 2019-nCoV Assay Kit Revenue by Region (2016-2021) & (US$ Million) Table 18. North America 2019-nCoV Assay Kit Sales by Country (2016-2021) & (K Units) Table 19. North America 2019-nCoV Assay Kit Sales Market Share by Country (2016-2021) Table 20. North America 2019-nCoV Assay Kit Revenue by Country (2016-2021) & (US$ Million) Table 21. North America 2019-nCoV Assay Kit Revenue Market Share by Country (2016-2021) Table 22. Europe 2019-nCoV Assay Kit Sales by Country (2016-2021) & (K Units) Table 23. Europe 2019-nCoV Assay Kit Sales Market Share by Country (2016-2021) Table 24. Europe 2019-nCoV Assay Kit Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe 2019-nCoV Assay Kit Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific 2019-nCoV Assay Kit Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific 2019-nCoV Assay Kit Sales Market Share by Region (2016-2021) Table 28. Asia Pacific 2019-nCoV Assay Kit Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific 2019-nCoV Assay Kit Revenue Market Share by Region (2016-2021) Table 30. Latin America 2019-nCoV Assay Kit Sales by Country (2016-2021) & (K Units) Table 31. Latin America 2019-nCoV Assay Kit Sales Market Share by Country (2016-2021) Table 32. Latin America 2019-nCoV Assay Kit Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America 2019-nCoV Assay Kit Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa 2019-nCoV Assay Kit Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa 2019-nCoV Assay Kit Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa 2019-nCoV Assay Kit Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa 2019-nCoV Assay Kit Revenue Market Share by Country (2016-2021) Table 38. Global 2019-nCoV Assay Kit Sales (K Units) by Type (2016-2021) Table 39. Global 2019-nCoV Assay Kit Sales Market Share by Type (2016-2021) Table 40. Global 2019-nCoV Assay Kit Revenue (Million US$) by Type (2016-2021) Table 41. Global 2019-nCoV Assay Kit Revenue Share by Type (2016-2021) Table 42. Global 2019-nCoV Assay Kit Price (US$/Unit) by Type (2016-2021) Table 43. Global 2019-nCoV Assay Kit Sales (K Units) by Application (2016-2021) Table 44. Global 2019-nCoV Assay Kit Sales Market Share by Application (2016-2021) Table 45. Global 2019-nCoV Assay Kit Revenue (Million US$) by Application (2016-2021) Table 46. Global 2019-nCoV Assay Kit Revenue Share by Application (2016-2021) Table 47. Global 2019-nCoV Assay Kit Price (US$/Unit) by Application (2016-2021) Table 48. Roche Corporation Information Table 49. Roche Description and Business Overview Table 50. Roche 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 51. Roche 2019-nCoV Assay Kit Product Table 52. Roche Recent Developments/Updates Table 53. Seegene Corporation Information Table 54. Seegene Description and Business Overview Table 55. Seegene 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 56. Seegene 2019-nCoV Assay Kit Product Table 57. Seegene Recent Developments/Updates Table 58. PharmACT Corporation Information Table 59. PharmACT Description and Business Overview Table 60. PharmACT 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 61. PharmACT 2019-nCoV Assay Kit Product Table 62. PharmACT Recent Developments/Updates Table 63. Everlywell Corporation Information Table 64. Everlywell Description and Business Overview Table 65. Everlywell 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 66. Everlywell 2019-nCoV Assay Kit Product Table 67. Everlywell Recent Developments/Updates Table 68. Biopanda Corporation Information Table 69. Biopanda Description and Business Overview Table 70. Biopanda 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 71. Biopanda 2019-nCoV Assay Kit Product Table 72. Biopanda Recent Developments/Updates Table 73. Mylab Discovery Corporation Information Table 74. Mylab Discovery Description and Business Overview Table 75. Mylab Discovery 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 76. Mylab Discovery 2019-nCoV Assay Kit Product Table 77. Mylab Discovery Recent Developments/Updates Table 78. Integrated DNA Technologies Corporation Information Table 79. Integrated DNA Technologies Description and Business Overview Table 80. Integrated DNA Technologies 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 81. Integrated DNA Technologies 2019-nCoV Assay Kit Product Table 82. Integrated DNA Technologies Recent Developments/Updates Table 83. Cosara Diagnostics Corporation Information Table 84. Cosara Diagnostics Description and Business Overview Table 85. Cosara Diagnostics 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 86. Cosara Diagnostics 2019-nCoV Assay Kit Product Table 87. Cosara Diagnostics Recent Developments/Updates Table 88. Solgent Corporation Information Table 89. Solgent Description and Business Overview Table 90. Solgent 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 91. Solgent 2019-nCoV Assay Kit Product Table 92. Solgent Recent Developments/Updates Table 93. Kogene Biotech Corporation Information Table 94. Kogene Biotech Description and Business Overview Table 95. Kogene Biotech 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 96. Kogene Biotech 2019-nCoV Assay Kit Product Table 97. Kogene Biotech Recent Developments/Updates Table 98. SD Biosensor Corporation Information Table 99. SD Biosensor Description and Business Overview Table 100. SD Biosensor 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 101. SD Biosensor 2019-nCoV Assay Kit Product Table 102. SD Biosensor Recent Developments/Updates Table 103. Biosewoom Corporation Information Table 104. Biosewoom Description and Business Overview Table 105. Biosewoom 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 106. Biosewoom 2019-nCoV Assay Kit Product Table 107. Biosewoom Recent Developments/Updates Table 108. Shanghai ZJ Bio-Tech Corporation Information Table 109. Shanghai ZJ Bio-Tech Description and Business Overview Table 110. Shanghai ZJ Bio-Tech 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 111. Shanghai ZJ Bio-Tech 2019-nCoV Assay Kit Product Table 112. Shanghai ZJ Bio-Tech Recent Developments/Updates Table 113. Shanghai Geneodx Biotech Corporation Information Table 114. Shanghai Geneodx Biotech Description and Business Overview Table 115. Shanghai Geneodx Biotech 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 116. Shanghai Geneodx Biotech 2019-nCoV Assay Kit Product Table 117. Shanghai Geneodx Biotech Recent Developments/Updates Table 118. INNOVITA Corporation Information Table 119. INNOVITA Description and Business Overview Table 120. INNOVITA 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 121. INNOVITA 2019-nCoV Assay Kit Product Table 122. INNOVITA Recent Developments/Updates Table 123. Genomics Biotech (Wuhan) Corporation Information Table 124. Genomics Biotech (Wuhan) Description and Business Overview Table 125. Genomics Biotech (Wuhan) 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 126. Genomics Biotech (Wuhan) 2019-nCoV Assay Kit Product Table 127. Genomics Biotech (Wuhan) Recent Developments/Updates Table 128. Zhongshan Daan Gene Corporation Information Table 129. Zhongshan Daan Gene Description and Business Overview Table 130. Zhongshan Daan Gene 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 131. Zhongshan Daan Gene 2019-nCoV Assay Kit Product Table 132. Zhongshan Daan Gene Recent Developments/Updates Table 133. Sanaure Corporation Information Table 134. Sanaure Description and Business Overview Table 135. Sanaure 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 136. Sanaure 2019-nCoV Assay Kit Product Table 137. Sanaure Recent Developments/Updates Table 138. Shanghai Bio-Germ Corporation Information Table 139. Shanghai Bio-Germ Description and Business Overview Table 140. Shanghai Bio-Germ 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 141. Shanghai Bio-Germ 2019-nCoV Assay Kit Product Table 142. Shanghai Bio-Germ Recent Developments/Updates Table 143. Guangzhou Wonfo Bio-Tech Corporation Information Table 144. Guangzhou Wonfo Bio-Tech Description and Business Overview Table 145. Guangzhou Wonfo Bio-Tech 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 146. Guangzhou Wonfo Bio-Tech 2019-nCoV Assay Kit Product Table 147. Guangzhou Wonfo Bio-Tech Recent Developments/Updates Table 148. Chengdu Boaojing Bio-Tech Corporation Information Table 149. Chengdu Boaojing Bio-Tech Description and Business Overview Table 150. Chengdu Boaojing Bio-Tech 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 151. Chengdu Boaojing Bio-Tech 2019-nCoV Assay Kit Product Table 152. Chengdu Boaojing Bio-Tech Recent Developments/Updates Table 153. Beijing XABT Corporation Information Table 154. Beijing XABT Description and Business Overview Table 155. Beijing XABT 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 156. Beijing XABT 2019-nCoV Assay Kit Product Table 157. Beijing XABT Recent Developments/Updates Table 158. Bioscience(Chongqing) Bio-Tech Corporation Information Table 159. Bioscience(Chongqing) Bio-Tech Description and Business Overview Table 160. Bioscience(Chongqing) Bio-Tech 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 161. Bioscience(Chongqing) Bio-Tech 2019-nCoV Assay Kit Product Table 162. Bioscience(Chongqing) Bio-Tech Recent Developments/Updates Table 163. Maccura Bio-Tech Corporation Information Table 164. Maccura Bio-Tech Description and Business Overview Table 165. Maccura Bio-Tech 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 166. Maccura Bio-Tech 2019-nCoV Assay Kit Product Table 167. Maccura Bio-Tech Recent Developments/Updates Table 168. Xiamen InnoDx Corporation Information Table 169. Xiamen InnoDx Description and Business Overview Table 170. Xiamen InnoDx 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 171. Xiamen InnoDx 2019-nCoV Assay Kit Product Table 172. Xiamen InnoDx Recent Developments/Updates Table 173. Guangdong Hecin-Scientific Corporation Information Table 174. Guangdong Hecin-Scientific Description and Business Overview Table 175. Guangdong Hecin-Scientific 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 176. Guangdong Hecin-Scientific 2019-nCoV Assay Kit Product Table 177. Guangdong Hecin-Scientific Recent Developments/Updates Table 178. Wuhan Easydiagnosis Biomedicine Corporation Information Table 179. Wuhan Easydiagnosis Biomedicine Description and Business Overview Table 180. Wuhan Easydiagnosis Biomedicine 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 181. Wuhan Easydiagnosis Biomedicine 2019-nCoV Assay Kit Product Table 182. Wuhan Easydiagnosis Biomedicine Recent Developments/Updates Table 183. Curative Corporation Information Table 184. Curative Description and Business Overview Table 185. Curative 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 186. Curative 2019-nCoV Assay Kit Product Table 187. Curative Recent Developments/Updates Table 188. Biolidics Corporation Information Table 189. Biolidics Description and Business Overview Table 190. Biolidics 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 191. Biolidics 2019-nCoV Assay Kit Product Table 192. Biolidics Recent Developments/Updates Table 193. Production Base and Market Concentration Rate of Raw Material Table 194. Key Suppliers of Raw Materials Table 195. 2019-nCoV Assay Kit Distributors List Table 196. 2019-nCoV Assay Kit Customers List Table 197. 2019-nCoV Assay Kit Market Trends Table 198. 2019-nCoV Assay Kit Growth Drivers Table 199. 2019-nCoV Assay Kit Market Restraints Table 200. Global 2019-nCoV Assay Kit Sales Forecast by Type (2022-2027) & (K Units) Table 201. Global 2019-nCoV Assay Kit Sales Market Share Forecast by Type (2022-2027) Table 202. Global 2019-nCoV Assay Kit Revenue Forecast by Type (2022-2027) & (US$ Million) Table 203. Global 2019-nCoV Assay Kit Revenue Market Share Forecast by Type (2022-2027) Table 204. Global 2019-nCoV Assay Kit Sales Forecast by Application (2022-2027) & (K Units) Table 205. Global 2019-nCoV Assay Kit Sales Market Share Forecast by Application (2022-2027) Table 206. Global 2019-nCoV Assay Kit Revenue Forecast by Application (2022-2027) & (US$ Million) Table 207. Global 2019-nCoV Assay Kit Revenue Market Share Forecast by Application (2022-2027) Table 208. Global 2019-nCoV Assay Kit Sales Forecast by Region (2022-2027) & (K Units) Table 209. Global 2019-nCoV Assay Kit Sales Market Share Forecast by Region (2022-2027) Table 210. Global 2019-nCoV Assay Kit Revenue Forecast by Region (2022-2027) & (US$ Million) Table 211. Global 2019-nCoV Assay Kit Revenue Market Share Forecast by Region (2022-2027) Table 212. Research Programs/Design for This Report Table 213. Key Data Information from Secondary Sources Table 214. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of 2019-nCoV Assay Kit Figure 2. Global 2019-nCoV Assay Kit Market Share by Type in 2020 & 2027 Figure 3. Nucleic Acid Detection Kit Product Picture Figure 4. Antibody Detection Kit Product Picture Figure 5. Global 2019-nCoV Assay Kit Market Share by Application in 2020 & 2027 Figure 6. Designated Hospital Figure 7. Diagnostic Center Figure 8. Scientific Research Figure 9. Port of Entry Figure 10. Individual Figure 11. Others Figure 12. Global 2019-nCoV Assay Kit Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global 2019-nCoV Assay Kit Market Size 2016-2027 (US$ Million) Figure 14. Global 2019-nCoV Assay Kit Sales 2016-2027 (K Units) Figure 15. Global 2019-nCoV Assay Kit Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 16. 2019-nCoV Assay Kit Sales Share by Manufacturers in 2020 Figure 17. Global 2019-nCoV Assay Kit Revenue Share by Manufacturers in 2020 Figure 18. The Global 5 and 10 Largest 2019-nCoV Assay Kit Players: Market Share by Revenue in 2020 Figure 19. 2019-nCoV Assay Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 20. Global 2019-nCoV Assay Kit Sales Market Share by Region (2016-2021) Figure 21. Global 2019-nCoV Assay Kit Sales Market Share by Region in 2020 Figure 22. Global 2019-nCoV Assay Kit Revenue Market Share by Region (2016-2021) Figure 23. Global 2019-nCoV Assay Kit Revenue Market Share by Region in 2020 Figure 24. U.S. 2019-nCoV Assay Kit Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Canada 2019-nCoV Assay Kit Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Germany 2019-nCoV Assay Kit Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. France 2019-nCoV Assay Kit Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. U.K. 2019-nCoV Assay Kit Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Italy 2019-nCoV Assay Kit Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Russia 2019-nCoV Assay Kit Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. China 2019-nCoV Assay Kit Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Japan 2019-nCoV Assay Kit Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. South Korea 2019-nCoV Assay Kit Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. India 2019-nCoV Assay Kit Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Australia 2019-nCoV Assay Kit Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Taiwan 2019-nCoV Assay Kit Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Indonesia 2019-nCoV Assay Kit Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Thailand 2019-nCoV Assay Kit Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Malaysia 2019-nCoV Assay Kit Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Philippines 2019-nCoV Assay Kit Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Vietnam 2019-nCoV Assay Kit Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Mexico 2019-nCoV Assay Kit Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Brazil 2019-nCoV Assay Kit Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Argentina 2019-nCoV Assay Kit Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Turkey 2019-nCoV Assay Kit Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Saudi Arabia 2019-nCoV Assay Kit Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. UAE 2019-nCoV Assay Kit Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Sales Market Share of 2019-nCoV Assay Kit by Type (2016-2021) Figure 49. Sales Market Share of 2019-nCoV Assay Kit by Application (2016-2021) Figure 50. Sales Market Share of 2019-nCoV Assay Kit by Application in 2020 Figure 51. Revenue Share of 2019-nCoV Assay Kit by Application (2016-2021) Figure 52. Revenue Share of 2019-nCoV Assay Kit by Application in 2020 Figure 53. Manufacturing Cost Structure of 2019-nCoV Assay Kit Figure 54. Manufacturing Process Analysis of 2019-nCoV Assay Kit Figure 55. 2019-nCoV Assay Kit Industrial Chain Analysis Figure 56. Channels of Distribution Figure 57. Distributors Profiles Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us